Innovo Therapeutics
PrivateLast Round
Seed
Dec 1, 2023
Total Funding Raised
$28.84M
Company Overview
Innovo Therapeutics is a biotechnology company that specializes in the discovery and development of novel protein degrader drugs for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovo Therapeutics Comparables
Compare Innovo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 85% | |
| PostEra | 84% | |
| Aigen Sciences | 83% | |
Innovo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2023 | ||||
| Angel | May 15, 2022 |
Innovo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiandao Fund | Seed |
| Ming Bioventures | Seed, Angel |
| Huajin Capital | Seed |
| CICC Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2022
$15M round led by Ming Bioventures
Innovo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innovo Therapeutics's valuation, stock price, and market status.